Management of traditional risk factors for the development and progression of chronic kidney disease

Chronic kidney disease (CKD) and its downstream complications (i.e. cardiovascular) are a major source of morbidity worldwide. Additionally, deaths due to CKD or CKD-attributable cardiovascular disease account for a sizeable proportion of global mortality. However, the advent of new pharmacotherapie...

Full description

Saved in:
Bibliographic Details
Published inClinical kidney journal Vol. 16; no. 11; pp. 1737 - 1750
Main Authors Lo, Robin, Narasaki, Yoko, Lei, Sean, Rhee, Connie M
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.11.2023
Subjects
Blood pressure
Cardiology
Chronic illnesses
Chronic kidney failure
CKJ Review
Clinical trials
Dapagliflozin
Denervation
Development and progression
Diabetes
Drug therapy
Health aspects
Hydrochlorothiazide
Hyperkalemia
Hypertension
Hypothyroidism
Ivabradine
Kidney diseases
Lifestyles
Mortality
Prevention
Public health
Risk factors
Testosterone
Thyroid hormones
Type 2 diabetes
Weight control
chronic kidney disease
risk factors
traditional
Online AccessGet full text

Cover

Abstract Chronic kidney disease (CKD) and its downstream complications (i.e. cardiovascular) are a major source of morbidity worldwide. Additionally, deaths due to CKD or CKD-attributable cardiovascular disease account for a sizeable proportion of global mortality. However, the advent of new pharmacotherapies, diagnostic tools, and global initiatives are directing greater attention to kidney health in the public health agenda, including the implementation of effective strategies that (i) prevent kidney disease, (ii) provide early CKD detection, and (iii) ameliorate CKD progression and its related complications. In this Review, we discuss major risk factors for incident CKD and CKD progression categorized across cardiovascular (i.e. hypertension, dyslipidemia, cardiorenal syndrome), endocrine (i.e. diabetes mellitus, hypothyroidism, testosterone), lifestyle (i.e. obesity, dietary factors, smoking), and genetic/environmental (i.e. CKDu/Mesoamerican nephropathy, APOL1, herbal nephropathy) domains, as well as scope, mechanistic underpinnings, and management. Lay Summary In this Review, we discuss major risk factors for incident chronic kidney disease (CKD) and CKD progression categorized across cardiovascular (i.e. hypertension, dyslipidaemia, cardiorenal syndrome), endocrine (i.e. diabetes mellitus, hypothyroidism, testosterone), lifestyle (i.e. obesity, dietary factors, smoking), and genetic/environmental (i.e. CKDu/Mesoamerican nephropathy, APOL1, herbal nephropathy) domains, as well as scope, mechanistic underpinnings, and management.
AbstractList Chronic kidney disease (CKD) and its downstream complications (i.e. cardiovascular) are a major source of morbidity worldwide. Additionally, deaths due to CKD or CKD-attributable cardiovascular disease account for a sizeable proportion of global mortality. However, the advent of new pharmacotherapies, diagnostic tools, and global initiatives are directing greater attention to kidney health in the public health agenda, including the implementation of effective strategies that (i) prevent kidney disease, (ii) provide early CKD detection, and (iii) ameliorate CKD progression and its related complications. In this Review, we discuss major risk factors for incident CKD and CKD progression categorized across cardiovascular (i.e. hypertension, dyslipidemia, cardiorenal syndrome), endocrine (i.e. diabetes mellitus, hypothyroidism, testosterone), lifestyle (i.e. obesity, dietary factors, smoking), and genetic/environmental (i.e. CKDu/Mesoamerican nephropathy, APOL1, herbal nephropathy) domains, as well as scope, mechanistic underpinnings, and management.Chronic kidney disease (CKD) and its downstream complications (i.e. cardiovascular) are a major source of morbidity worldwide. Additionally, deaths due to CKD or CKD-attributable cardiovascular disease account for a sizeable proportion of global mortality. However, the advent of new pharmacotherapies, diagnostic tools, and global initiatives are directing greater attention to kidney health in the public health agenda, including the implementation of effective strategies that (i) prevent kidney disease, (ii) provide early CKD detection, and (iii) ameliorate CKD progression and its related complications. In this Review, we discuss major risk factors for incident CKD and CKD progression categorized across cardiovascular (i.e. hypertension, dyslipidemia, cardiorenal syndrome), endocrine (i.e. diabetes mellitus, hypothyroidism, testosterone), lifestyle (i.e. obesity, dietary factors, smoking), and genetic/environmental (i.e. CKDu/Mesoamerican nephropathy, APOL1, herbal nephropathy) domains, as well as scope, mechanistic underpinnings, and management.
Chronic kidney disease (CKD) and its downstream complications (i.e. cardiovascular) are a major source of morbidity worldwide. Additionally, deaths due to CKD or CKD-attributable cardiovascular disease account for a sizeable proportion of global mortality. However, the advent of new pharmacotherapies, diagnostic tools, and global initiatives are directing greater attention to kidney health in the public health agenda, including the implementation of effective strategies that (i) prevent kidney disease, (ii) provide early CKD detection, and (iii) ameliorate CKD progression and its related complications. In this Review, we discuss major risk factors for incident CKD and CKD progression categorized across cardiovascular (i.e. hypertension, dyslipidemia, cardiorenal syndrome), endocrine (i.e. diabetes mellitus, hypothyroidism, testosterone), lifestyle (i.e. obesity, dietary factors, smoking), and genetic/environmental (i.e. CKDu/Mesoamerican nephropathy, APOL1, herbal nephropathy) domains, as well as scope, mechanistic underpinnings, and management.
Chronic kidney disease (CKD) and its downstream complications (i.e. cardiovascular) are a major source of morbidity worldwide. Additionally, deaths due to CKD or CKD-attributable cardiovascular disease account for a sizeable proportion of global mortality. However, the advent of new pharmacotherapies, diagnostic tools, and global initiatives are directing greater attention to kidney health in the public health agenda, including the implementation of effective strategies that (i) prevent kidney disease, (ii) provide early CKD detection, and (iii) ameliorate CKD progression and its related complications. In this Review, we discuss major risk factors for incident CKD and CKD progression categorized across cardiovascular (i.e. hypertension, dyslipidemia, cardiorenal syndrome), endocrine (i.e. diabetes mellitus, hypothyroidism, testosterone), lifestyle (i.e. obesity, dietary factors, smoking), and genetic/environmental (i.e. CKDu/Mesoamerican nephropathy, APOL1, herbal nephropathy) domains, as well as scope, mechanistic underpinnings, and management. Lay Summary In this Review, we discuss major risk factors for incident chronic kidney disease (CKD) and CKD progression categorized across cardiovascular (i.e. hypertension, dyslipidaemia, cardiorenal syndrome), endocrine (i.e. diabetes mellitus, hypothyroidism, testosterone), lifestyle (i.e. obesity, dietary factors, smoking), and genetic/environmental (i.e. CKDu/Mesoamerican nephropathy, APOL1, herbal nephropathy) domains, as well as scope, mechanistic underpinnings, and management.
Chronic kidney disease (CKD) and its downstream complications (i.e. cardiovascular) are a major source of morbidity worldwide. Additionally, deaths due to CKD or CKD-attributable cardiovascular disease account for a sizeable proportion of global mortality. However, the advent of new pharmacotherapies, diagnostic tools, and global initiatives are directing greater attention to kidney health in the public health agenda, including the implementation of effective strategies that (i) prevent kidney disease, (ii) provide early CKD detection, and (iii) ameliorate CKD progression and its related complications. In this Review, we discuss major risk factors for incident CKD and CKD progression categorized across cardiovascular (i.e. hypertension, dyslipidemia, cardiorenal syndrome), endocrine (i.e. diabetes mellitus, hypothyroidism, testosterone), lifestyle (i.e. obesity, dietary factors, smoking), and genetic/environmental (i.e. CKDu/Mesoamerican nephropathy, APOL1, herbal nephropathy) domains, as well as scope, mechanistic underpinnings, and management. LAY SUMMARY In this Review, we discuss major risk factors for incident chronic kidney disease (CKD) and CKD progression categorized across cardiovascular (i.e. hypertension, dyslipidaemia, cardiorenal syndrome), endocrine (i.e. diabetes mellitus, hypothyroidism, testosterone), lifestyle (i.e. obesity, dietary factors, smoking), and genetic/environmental (i.e. CKDu/Mesoamerican nephropathy, APOL1, herbal nephropathy) domains, as well as scope, mechanistic underpinnings, and management. Keywords: chronic kidney disease, risk factors, traditional
ABSTRACT Chronic kidney disease (CKD) and its downstream complications (i.e. cardiovascular) are a major source of morbidity worldwide. Additionally, deaths due to CKD or CKD-attributable cardiovascular disease account for a sizeable proportion of global mortality. However, the advent of new pharmacotherapies, diagnostic tools, and global initiatives are directing greater attention to kidney health in the public health agenda, including the implementation of effective strategies that (i) prevent kidney disease, (ii) provide early CKD detection, and (iii) ameliorate CKD progression and its related complications. In this Review, we discuss major risk factors for incident CKD and CKD progression categorized across cardiovascular (i.e. hypertension, dyslipidemia, cardiorenal syndrome), endocrine (i.e. diabetes mellitus, hypothyroidism, testosterone), lifestyle (i.e. obesity, dietary factors, smoking), and genetic/environmental (i.e. CKDu/Mesoamerican nephropathy, APOL1, herbal nephropathy) domains, as well as scope, mechanistic underpinnings, and management.
Audience Academic
Author Narasaki, Yoko
Lo, Robin
Rhee, Connie M
Lei, Sean
Author_xml – sequence: 1
  givenname: Robin
  surname: Lo
  fullname: Lo, Robin
– sequence: 2
  givenname: Yoko
  surname: Narasaki
  fullname: Narasaki, Yoko
– sequence: 3
  givenname: Sean
  surname: Lei
  fullname: Lei, Sean
– sequence: 4
  givenname: Connie M
  surname: Rhee
  fullname: Rhee, Connie M
  email: crhee1@uci.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37915906$$D View this record in MEDLINE/PubMed
BookMark eNp9ks9rFDEUxwep2Fp78i4BQQTZNj8nmZOUYlWoeNFzyCYvu9mdSdZkptD_3mx3XW1Rk0NC8vl-897Le94cxRShaV4SfE5wxy7senVRvHEEkyfNCcVczZQg7Oiwx-K4OStlheuoN5iLZ80xkx0RHW5PGvfFRLOAAeKIkkdjNi6MIUXToxzKGnljx5QL8imjcQnIwS30aXPPm-jQJqdFhlKqZKu3y5xisGgdXIQ75EIBU-BF89SbvsDZfj1tvl9_-Hb1aXbz9ePnq8ubmRWSjzPV0g5aTzFVHFPrDacUJHVceSoZg850ztDOtdRiTATMO2k562odfGvmTrHT5v3OdzPNB3C2BplNrzc5DCbf6WSCfngTw1Iv0q0muCUtF7w6vN075PRjgjLqIRQLfW8ipKloqpQQTLWYVvT1I3SVplwLVzQjkiguJRO_qYXpQYfoU33Ybk31pZRdJZRoK3X-F6pOB0Ow9cd9qOcPBK_-zPSQ4q-PrcC7HWBzKiWDPyAE623n6No5et85lSaPaBtGs-2DGkfo_6F5s9OkafNf859Xv9RX
CitedBy_id crossref_primary_10_1136_bmjdrc_2023_003832
crossref_primary_10_3390_nu16234238
crossref_primary_10_1093_ckj_sfae345
crossref_primary_10_3390_nu17061058
crossref_primary_10_3390_antiox13010090
crossref_primary_10_1111_acel_14453
crossref_primary_10_1080_0886022X_2025_2478320
crossref_primary_10_3390_jcm13030678
crossref_primary_10_1016_j_jcte_2024_100365
crossref_primary_10_1080_0886022X_2024_2417742
crossref_primary_10_3389_fnut_2025_1519612
Cites_doi 10.2215/CJN.06080809
10.1111/j.1523-1755.2004.00497.x
10.1038/sj.ki.5002017
10.1016/j.nut.2017.08.015
10.1056/NEJMoa1712231
10.1371/journal.pone.0158765
10.1016/S0140-6736(09)62100-0
10.1161/ATVBAHA.117.309756
10.1093/ndt/gfp640
10.15585/mmwr.mm6946a4
10.1681/ASN.2017020148
10.1681/ASN.2007060693
10.1016/j.jacc.2017.11.006
10.1056/NEJM199704173361601
10.1056/NEJMoa2025845
10.1111/j.1751-7176.2008.00016.x
10.1056/NEJM200105313442201
10.1016/j.kint.2020.06.019
10.1016/S0140-6736(11)60739-3
10.3390/nu11040722
10.1161/CIRCULATIONAHA.114.010676
10.1093/ndt/gfy289
10.1111/j.1523-1755.2005.00169.x
10.1001/jama.288.19.2421
10.1681/ASN.2011111062
10.2215/CJN.01230122
10.1007/s11906-018-0864-0
10.1016/j.diabres.2016.09.016
10.2215/CJN.08530815
10.1038/ki.2014.31
10.2215/CJN.09320913
10.1038/sj.ki.5002011
10.1093/ckj/sfac151
10.1681/ASN.2008050549
10.1038/ncomms9078
10.1016/S1550-8579(07)80005-2
10.1053/j.ajkd.2018.12.044
10.1097/TP.0000000000002509
10.1001/jama.2016.4447
10.1097/MED.0000000000000275
10.1056/NEJMoa1111732
10.1186/1471-2458-10-731
10.2215/CJN.11571017
10.1371/journal.pone.0238111
10.1053/j.ajkd.2013.08.014
10.1016/S2213-8587(16)30156-5
10.1016/j.coi.2009.05.024
10.1007/s11684-017-0570-3
10.1210/jc.2012-1663
10.1681/ASN.V112319
10.1056/NEJMoa1811744
10.3389/fphar.2020.569551
10.1016/j.amjmed.2014.10.014
10.1056/NEJMoa2024816
10.1016/S0140-6736(15)01225-8
10.1016/j.trstmh.2007.05.006
10.1136/bmj.m824
10.3390/nu12071931
10.1016/S0140-6736(18)30951-6
10.1161/CIRCULATIONAHA.118.037076
10.1056/NEJMoa1409077
10.1016/j.xkme.2020.04.007
10.1016/j.pop.2020.08.004
10.1038/hr.2016.51
10.1056/NEJMoa1812389
10.5527/wjn.v3.i3.50
10.1016/j.cardfail.2007.03.011
10.2337/dc14-1020
10.1053/j.ajkd.2016.04.012
10.1056/NEJMoa0802743
10.1093/ckj/sfaa200
10.1038/ki.2014.270
10.1038/ki.2013.173
10.1681/ASN.2020030384
10.1056/NEJMoa2110730
10.1038/hr.2010.139
10.1016/j.envres.2015.07.007
10.1056/NEJMoa043399
10.1159/000441265
10.1093/ndt/gft302
10.1016/S2213-8587(18)30104-9
10.1016/j.diabet.2016.12.010
10.1093/eurheartj/eht386
10.1016/S0140-6736(10)61198-1
10.1185/03007995.2015.1094044
10.1056/NEJMoa011161
10.1016/j.jacc.2021.04.079
10.1038/s41581-020-0268-7
10.1001/jamainternmed.2017.4377
10.1681/ASN.2015010022
10.1016/j.jacc.2019.12.059
10.1056/NEJMoa2110956
10.1161/ATVBAHA.113.300156
10.1093/ndt/gfu303
10.1161/HYPERTENSIONAHA.119.11684
10.1056/NEJMoa1009540
10.1056/NEJMoa1001286
10.1038/s41581-019-0244-2
10.2337/diacare.26.4.1258
10.2215/CJN.06920712
10.1016/S0140-6736(19)31150-X
10.4065/82.5.561
10.1001/jama.2016.15450
10.1056/NEJMoa1511939
10.1016/j.kint.2020.11.003
10.2215/CJN.11840919
10.1093/ndt/gfm091
10.1053/j.ajkd.2005.08.015
10.1681/ASN.2012121180
10.1056/NEJMoa2105675
10.1056/NEJMoa1616011
10.1161/HYPERTENSIONAHA.116.07553
10.2147/IJNRD.S270709
10.1056/NEJM199909023411001
10.1172/JCI46263
10.1056/NEJMoa053107
10.1056/NEJMoa0802987
10.1089/thy.2012.0475
10.1046/j.1523-1755.2002.00626.x
10.1056/NEJMoa2022190
10.1016/j.diabres.2019.107843
10.1056/NEJMoa0808431
10.1056/NEJMoa1611925
10.1016/j.kisu.2017.07.003
10.1053/j.ajkd.2014.06.014
10.2215/CJN.00530119
10.1056/NEJM199209033271001
10.7326/0003-4819-123-10-199511150-00003
10.1186/s12882-020-01907-5
10.1681/ASN.2020050682
10.1053/j.ajkd.2005.06.007
10.1093/ntr/ntaa071
10.1016/S0140-6736(05)71082-5
ContentType Journal Article
Copyright The Author(s) 2023. Published by Oxford University Press on behalf of the ERA. 2023
The Author(s) 2023. Published by Oxford University Press on behalf of the ERA.
COPYRIGHT 2023 Oxford University Press
The Author(s) 2023. Published by Oxford University Press on behalf of the ERA. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2023. Published by Oxford University Press on behalf of the ERA. 2023
– notice: The Author(s) 2023. Published by Oxford University Press on behalf of the ERA.
– notice: COPYRIGHT 2023 Oxford University Press
– notice: The Author(s) 2023. Published by Oxford University Press on behalf of the ERA. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID TOX
AAYXX
CITATION
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1093/ckj/sfad101
DatabaseName Oxford Journals Open Access Collection
CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed



CrossRef

Publicly Available Content Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: TOX
  name: Oxford Journals Open Access Collection
  url: https://academic.oup.com/journals/
  sourceTypes: Publisher
– sequence: 3
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 2048-8513
EndPage 1750
ExternalDocumentID PMC10616454
A779353856
37915906
10_1093_ckj_sfad101
10.1093/ckj/sfad101
Genre Journal Article
Review
GrantInformation_xml – fundername: NIDDK NIH HHS
  grantid: R01 DK124138
– fundername: ;
– fundername: ;
  grantid: R01-DK122767; R01-DK124138
GroupedDBID 0R~
4.4
53G
5VS
AAFWJ
AAMVS
AAPPN
AAPXW
AAVAP
ABDBF
ABEJV
ABKDP
ABNKS
ABOCM
ABPTD
ABXVV
ABZBJ
ACGFS
ADBBV
ADEYI
ADHZD
ADOCK
ADRAZ
AEGXH
AENZO
AFULF
ALMA_UNASSIGNED_HOLDINGS
ALUQC
AOIJS
BAYMD
BCNDV
BTTYL
CIDKT
D~K
EBS
EE~
EJD
F9B
GROUPED_DOAJ
H13
H5~
HYE
HZ~
IAO
IHR
INH
ITC
J21
KQ8
KSI
M48
M49
M~E
NU-
OAWHX
OJQWA
OK1
PEELM
Q1.
ROL
ROX
RPM
RW1
RXO
TJX
TOX
7X7
8FI
8FJ
AAYXX
ABGNP
ABUWG
ACUHS
AFKRA
AFPKN
AMNDL
BENPR
CCPQU
CITATION
FYUFA
HMCUK
PHGZM
PHGZT
PIMPY
UKHRP
NPM
PMFND
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c574t-8629e6f2028402cfa422e72d48f2733e9a9da29d62c0015eb97c439109f6abd83
IEDL.DBID M48
ISSN 2048-8505
IngestDate Thu Aug 21 18:36:41 EDT 2025
Fri Jul 11 03:42:48 EDT 2025
Mon Jun 30 12:16:29 EDT 2025
Tue Jun 17 22:20:19 EDT 2025
Tue Jun 10 21:13:36 EDT 2025
Wed Feb 19 02:10:41 EST 2025
Thu Apr 24 23:04:57 EDT 2025
Tue Jul 01 03:33:39 EDT 2025
Tue Nov 19 12:02:17 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords chronic kidney disease
risk factors
traditional
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
https://creativecommons.org/licenses/by-nc/4.0
The Author(s) 2023. Published by Oxford University Press on behalf of the ERA.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c574t-8629e6f2028402cfa422e72d48f2733e9a9da29d62c0015eb97c439109f6abd83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1093/ckj/sfad101
PMID 37915906
PQID 3171847735
PQPubID 7089197
PageCount 14
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10616454
proquest_miscellaneous_2885538602
proquest_journals_3171847735
gale_infotracmisc_A779353856
gale_infotracacademiconefile_A779353856
pubmed_primary_37915906
crossref_primary_10_1093_ckj_sfad101
crossref_citationtrail_10_1093_ckj_sfad101
oup_primary_10_1093_ckj_sfad101
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-11-01
PublicationDateYYYYMMDD 2023-11-01
PublicationDate_xml – month: 11
  year: 2023
  text: 2023-11-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle Clinical kidney journal
PublicationTitleAlternate Clin Kidney J
PublicationYear 2023
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References Baigent (2023103104581345600_bib59) 2011; 377
2023103104581345600_bib123
Saeedi (2023103104581345600_bib72) 2019; 157
(2023103104581345600_bib116) 2010
Shin (2023103104581345600_bib91) 2013; 23
Incorporated VP (2023103104581345600_bib140)
Jo (2023103104581345600_bib121) 2020; 15
Mills (2023103104581345600_bib26) 2016; 315
Group (2023103104581345600_bib75) 2008; 358
Kheirkhah (2023103104581345600_bib50) 2022; 17
Peterson (2023103104581345600_bib18) 1995; 123
Lee (2023103104581345600_bib122) 2021; 23
(2023103104581345600_bib78) 2020; 98
Brenner (2023103104581345600_bib79) 2001; 345
System USRD (2023103104581345600_bib8) 2021
Heerspink (2023103104581345600_bib86) 2020; 383
Felker (2023103104581345600_bib62) 2020; 75
Wesseling (2023103104581345600_bib125) 2014; 63
Packer (2023103104581345600_bib63) 2001; 344
Egan (2023103104581345600_bib7) 2014; 130
Group (2023103104581345600_bib11) 2015; 373
Neugarten (2023103104581345600_bib97) 2007; 4
Krikken (2023103104581345600_bib102) 2007; 71
Ganguli (2023103104581345600_bib127) 2016; 68
Pitt (2023103104581345600_bib65) 1999; 341
Tozawa (2023103104581345600_bib49) 2002; 62
Bardia (2023103104581345600_bib141) 2007; 82
Liu (2023103104581345600_bib99) 2011; 2011
Whelton (2023103104581345600_bib32) 2018; 71
Wanner (2023103104581345600_bib54) 2014; 85
Gelber (2023103104581345600_bib100) 2005; 46
Divers (2023103104581345600_bib138) 2013; 84
Lo (2023103104581345600_bib87) 2005; 67
Appel (2023103104581345600_bib111) 1997; 336
Schlondorff (2023103104581345600_bib96) 2009; 20
Malhotra (2023103104581345600_bib24) 2017; 177
Mills (2023103104581345600_bib6) 2020; 16
Swedberg (2023103104581345600_bib66) 2010; 376
Palmer (2023103104581345600_bib58) 2014
Liu (2023103104581345600_bib94) 2015; 31
Felizardo (2023103104581345600_bib103) 2014; 3
Agarwal (2023103104581345600_bib39) 2021; 385
Drawz (2023103104581345600_bib14) 2016; 11
Tang (2023103104581345600_bib69) 2010; 363
Bolignano (2023103104581345600_bib105) 2013; 28
Xu (2023103104581345600_bib143) 2020; 11
Bello (2023103104581345600_bib104) 2007; 22
Widmer (2023103104581345600_bib113) 2015; 128
Xu (2023103104581345600_bib107) 2017; 11
Messner (2023103104581345600_bib118) 2014; 34
Vogt (2023103104581345600_bib27) 2008; 19
Kandzari (2023103104581345600_bib30) 2018; 391
Larsen (2023103104581345600_bib139) 2013; 24
Bakris (2023103104581345600_bib36) 2020; 383
Damman (2023103104581345600_bib60) 2014; 35
Force USPST (2023103104581345600_bib53) 2016; 316
Clegg (2023103104581345600_bib112) 2020; 2
Minutolo (2023103104581345600_bib16) 2014; 64
Duckworth (2023103104581345600_bib77) 2009; 360
Pays (2023103104581345600_bib133) 2009; 21
Hovind (2023103104581345600_bib73) 2003; 26
Kalantar-Zadeh (2023103104581345600_bib109) 2020; 12
He (2023103104581345600_bib25) 2016; 27
Kramer (2023103104581345600_bib101) 2005; 46
Nichols (2023103104581345600_bib137) 2015; 87
Mann (2023103104581345600_bib82) 2017; 377
Booth (2023103104581345600_bib13) 2016; 68
Filippatos (2023103104581345600_bib37) 2021; 78
Kelly (2023103104581345600_bib114) 2021; 32
Ortiz (2023103104581345600_bib4) 2022; 15
Garcia-Trabanino (2023103104581345600_bib128) 2015; 142
Bakris (2023103104581345600_bib45) 2010; 375
McMurray (2023103104581345600_bib67) 2014; 371
Kidney Disease: Improving Global Outcomes Blood Pressure Work G (2023103104581345600_bib17) 2021; 99
Friedman (2023103104581345600_bib134) 2011; 121
Ma (2023103104581345600_bib136) 2019; 103
Wanigasuriya (2023103104581345600_bib126) 2007; 101
Bach (2023103104581345600_bib108) 2019; 14
Gerstein (2023103104581345600_bib81) 2019; 394
Sanchez Polo (2023103104581345600_bib130) 2020; 13
Perkovic (2023103104581345600_bib85) 2019; 380
Bardy (2023103104581345600_bib70) 2005; 352
Bonner (2023103104581345600_bib74) 2020; 47
Mafra (2023103104581345600_bib110) 2018; 46
Yacoub (2023103104581345600_bib120) 2010; 10
Action to Control Cardiovascular Risk in Diabetes Study G (2023103104581345600_bib10) 2008; 358
Neal (2023103104581345600_bib84) 2017; 377
Scheen (2023103104581345600_bib42) 2017; 43
Heywood (2023103104581345600_bib61) 2007; 13
Packer (2023103104581345600_bib68) 2020; 383
Verzola (2023103104581345600_bib98) 2004; 65
Banegas (2023103104581345600_bib15) 2018; 378
Yamagata (2023103104581345600_bib48) 2007; 71
Shin (2023103104581345600_bib90) 2012; 97
Cheung (2023103104581345600_bib22) 2017; 28
Wiviott (2023103104581345600_bib83) 2019; 380
Luyckx (2023103104581345600_bib144) 2017; 7
Marklund (2023103104581345600_bib29) 2020; 369
Pitt (2023103104581345600_bib38) 2021; 385
Rhee (2023103104581345600_bib88) 2016; 23
Hering (2023103104581345600_bib31) 2012; 23
Carney (2023103104581345600_bib3) 2020; 16
(2023103104581345600_bib55) 2002; 360
Ohkuma (2023103104581345600_bib124) 2016; 39
Mehrotra (2023103104581345600_bib5) 2019; 14
Neal (2023103104581345600_bib28) 2021; 385
Rahman (2023103104581345600_bib57) 2014; 9
Rhee (2023103104581345600_bib93) 2013; 8
Rosenstein (2023103104581345600_bib52) 2000
Ku (2023103104581345600_bib9) 2019; 74
Group (2023103104581345600_bib76) 2011; 365
Vanwalleghem (2023103104581345600_bib135) 2015; 6
Bajaj (2023103104581345600_bib132) 2017; 37
Yang (2023103104581345600_bib142) 2018; 13
Hill (2023103104581345600_bib2) 2016; 11
Cholesterol Treatment Trialists C (2023103104581345600_bib56) 2016; 4
Neugarten (2023103104581345600_bib95) 2000; 11
Collaboration GBDCKD (2023103104581345600_bib1) 2020; 395
Scheen (2023103104581345600_bib43) 2016; 121
Kalaitzidis (2023103104581345600_bib46) 2018; 20
Roncal-Jimenez (2023103104581345600_bib129) 2016; 41
Liang (2023103104581345600_bib47) 2020; 21
Stavljenic-Rukavina (2023103104581345600_bib131) 2009; 20
Kovesdy (2023103104581345600_bib71) 2021; 14
Cornelius (2023103104581345600_bib117) 2020; 69
Chung (2023103104581345600_bib35) 2020; 2020
Fu (2023103104581345600_bib34) 2021; 32
Wilcox (2023103104581345600_bib40) 2020; 75
Pfeffer (2023103104581345600_bib64) 1992; 327
Afshinnia (2023103104581345600_bib106) 2010; 25
Ruggenenti (2023103104581345600_bib20) 2005; 365
Rhee (2023103104581345600_bib89) 2015; 30
Kario (2023103104581345600_bib41) 2019; 139
Kalantar-Zadeh (2023103104581345600_bib115) 2010; 5
Toto (2023103104581345600_bib44) 2008; 10
Tuttle (2023103104581345600_bib80) 2018; 6
InterAct (2023103104581345600_bib119) 2014; 37
Hou (2023103104581345600_bib33) 2006; 354
You (2023103104581345600_bib92) 2019; 34
Gai (2023103104581345600_bib51) 2019; 11
Ettehad (2023103104581345600_bib23) 2016; 387
Group (2023103104581345600_bib21) 2010; 362
Wright (2023103104581345600_bib19) 2002; 288
Kanno (2023103104581345600_bib12) 2010; 33
References_xml – volume: 5
  start-page: 519
  year: 2010
  ident: 2023103104581345600_bib115
  article-title: Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.06080809
– volume: 65
  start-page: 1252
  year: 2004
  ident: 2023103104581345600_bib98
  article-title: Testosterone promotes apoptotic damage in human renal tubular cells
  publication-title: Kidney Int
  doi: 10.1111/j.1523-1755.2004.00497.x
– volume: 71
  start-page: 159
  year: 2007
  ident: 2023103104581345600_bib48
  article-title: Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study
  publication-title: Kidney Int
  doi: 10.1038/sj.ki.5002017
– volume: 46
  start-page: 26
  year: 2018
  ident: 2023103104581345600_bib110
  article-title: Red meat intake in chronic kidney disease patients: two sides of the coin
  publication-title: Nutrition
  doi: 10.1016/j.nut.2017.08.015
– volume: 378
  start-page: 1509
  year: 2018
  ident: 2023103104581345600_bib15
  article-title: Relationship between clinic and ambulatory blood-pressure measurements and mortality
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1712231
– volume: 11
  start-page: e0158765
  year: 2016
  ident: 2023103104581345600_bib2
  article-title: Global prevalence of chronic kidney disease - a systematic review and meta-analysis
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0158765
– volume: 375
  start-page: 1173
  year: 2010
  ident: 2023103104581345600_bib45
  article-title: Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial
  publication-title: Lancet North Am Ed
  doi: 10.1016/S0140-6736(09)62100-0
– volume: 37
  start-page: 1587
  year: 2017
  ident: 2023103104581345600_bib132
  article-title: APOL1 and cardiovascular disease: a story in evolution
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.117.309756
– ident: 2023103104581345600_bib123
  article-title: Smoking Cessation: a Report of the Surgeon General. 2020. Publications and Reports of the Surgeon General
– volume: 25
  start-page: 1173
  year: 2010
  ident: 2023103104581345600_bib106
  article-title: Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts
  publication-title: Nephrol Dialysis Transpl
  doi: 10.1093/ndt/gfp640
– volume: 69
  start-page: 1736
  year: 2020
  ident: 2023103104581345600_bib117
  article-title: Tobacco product use among adults - United States, 2019
  publication-title: Morb Mortal Wkly Rep
  doi: 10.15585/mmwr.mm6946a4
– volume: 28
  start-page: 2812
  year: 2017
  ident: 2023103104581345600_bib22
  article-title: Effects of intensive BP control in CKD
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2017020148
– volume: 19
  start-page: 999
  year: 2008
  ident: 2023103104581345600_bib27
  article-title: Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2007060693
– volume: 71
  start-page: e127
  year: 2018
  ident: 2023103104581345600_bib32
  article-title: 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2017.11.006
– volume: 336
  start-page: 1117
  year: 1997
  ident: 2023103104581345600_bib111
  article-title: A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199704173361601
– volume: 383
  start-page: 2219
  year: 2020
  ident: 2023103104581345600_bib36
  article-title: Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2025845
– volume: 10
  start-page: 761
  year: 2008
  ident: 2023103104581345600_bib44
  article-title: Effects of calcium channel blockers on proteinuria in patients with diabetic nephropathy
  publication-title: J Clin Hypertens
  doi: 10.1111/j.1751-7176.2008.00016.x
– volume: 344
  start-page: 1651
  year: 2001
  ident: 2023103104581345600_bib63
  article-title: Effect of carvedilol on survival in severe chronic heart failure
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200105313442201
– volume: 98
  start-page: S1
  year: 2020
  ident: 2023103104581345600_bib78
  article-title: Kidney Disease: Improving Global Outcomes Diabetes Work G. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
  publication-title: Kidney Int
  doi: 10.1016/j.kint.2020.06.019
– volume: 377
  start-page: 2181
  year: 2011
  ident: 2023103104581345600_bib59
  article-title: The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
  publication-title: Lancet North Am Ed
  doi: 10.1016/S0140-6736(11)60739-3
– volume: 11
  start-page: 722
  year: 2019
  ident: 2023103104581345600_bib51
  article-title: Lipid accumulation and chronic kidney disease
  publication-title: Nutrients
  doi: 10.3390/nu11040722
– volume: 2020
  start-page: CD007004
  year: 2020
  ident: 2023103104581345600_bib35
  article-title: Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease
  publication-title: Cochrane Database Syst Rev
– volume: 130
  start-page: 1692
  year: 2014
  ident: 2023103104581345600_bib7
  article-title: Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.114.010676
– volume: 34
  start-page: 2095
  year: 2019
  ident: 2023103104581345600_bib92
  article-title: Association of thyroid status prior to transition to end-stage renal disease with early dialysis mortality
  publication-title: Nephrol Dialysis Transpl
  doi: 10.1093/ndt/gfy289
– volume: 67
  start-page: 1047
  year: 2005
  ident: 2023103104581345600_bib87
  article-title: Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease
  publication-title: Kidney Int
  doi: 10.1111/j.1523-1755.2005.00169.x
– volume: 288
  start-page: 2421
  year: 2002
  ident: 2023103104581345600_bib19
  article-title: Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial
  publication-title: JAMA
  doi: 10.1001/jama.288.19.2421
– volume: 23
  start-page: 1250
  year: 2012
  ident: 2023103104581345600_bib31
  article-title: Renal denervation in moderate to severe CKD
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2011111062
– volume: 17
  start-page: 809
  year: 2022
  ident: 2023103104581345600_bib50
  article-title: PCSK9 and cardiovascular disease in individuals with moderately decreased kidney function
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.01230122
– volume: 20
  start-page: 64
  year: 2018
  ident: 2023103104581345600_bib46
  article-title: Treatment of hypertension in chronic kidney disease
  publication-title: Curr Hypertens Rep
  doi: 10.1007/s11906-018-0864-0
– volume: 121
  start-page: 204
  year: 2016
  ident: 2023103104581345600_bib43
  article-title: Effects of reducing blood pressure on cardiovascular outcomes and mortality in patients with type 2 diabetes: focus on SGLT2 inhibitors and EMPA-REG OUTCOME
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2016.09.016
– volume: 11
  start-page: 642
  year: 2016
  ident: 2023103104581345600_bib14
  article-title: Masked hypertension and elevated nighttime blood pressure in CKD: prevalence and association with target organ damage
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.08530815
– volume: 85
  start-page: 1303
  year: 2014
  ident: 2023103104581345600_bib54
  article-title: Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group M. KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient
  publication-title: Kidney Int
  doi: 10.1038/ki.2014.31
– volume: 9
  start-page: 1190
  year: 2014
  ident: 2023103104581345600_bib57
  article-title: Relation of serum lipids and lipoproteins with progression of CKD: the CRIC study
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.09320913
– volume: 71
  start-page: 260
  year: 2007
  ident: 2023103104581345600_bib102
  article-title: The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men
  publication-title: Kidney Int
  doi: 10.1038/sj.ki.5002011
– volume: 15
  start-page: 1793
  year: 2022
  ident: 2023103104581345600_bib4
  article-title: Ageing meets kidney disease
  publication-title: Clin Kidney J
  doi: 10.1093/ckj/sfac151
– volume: 20
  start-page: 1179
  year: 2009
  ident: 2023103104581345600_bib96
  article-title: The mesangial cell revisited: no cell is an island
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2008050549
– volume: 6
  start-page: 8078
  year: 2015
  ident: 2023103104581345600_bib135
  article-title: Coupling of lysosomal and mitochondrial membrane permeabilization in trypanolysis by APOL1
  publication-title: Nat Commun
  doi: 10.1038/ncomms9078
– volume: 4
  start-page: 31
  year: 2007
  ident: 2023103104581345600_bib97
  article-title: Estrogen and oxidative stress
  publication-title: Gender Medicine
  doi: 10.1016/S1550-8579(07)80005-2
– volume: 74
  start-page: 120
  year: 2019
  ident: 2023103104581345600_bib9
  article-title: Hypertension in CKD: core curriculum 2019
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2018.12.044
– volume: 103
  start-page: 487
  year: 2019
  ident: 2023103104581345600_bib136
  article-title: Mechanisms of injury in APOL1-associated kidney disease
  publication-title: Transplantation
  doi: 10.1097/TP.0000000000002509
– volume: 315
  start-page: 2200
  year: 2016
  ident: 2023103104581345600_bib26
  article-title: Sodium excretion and the risk of cardiovascular disease in patients with chronic kidney disease
  publication-title: JAMA
  doi: 10.1001/jama.2016.4447
– volume: 395
  start-page: 709
  year: 2020
  ident: 2023103104581345600_bib1
  article-title: Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
  publication-title: Lancet North Am Ed
– volume: 23
  start-page: 407
  year: 2016
  ident: 2023103104581345600_bib88
  article-title: The interaction between thyroid and kidney disease: an overview of the evidence
  publication-title: Curr Opin Endocrinol Diabetes Obes
  doi: 10.1097/MED.0000000000000275
– volume: 365
  start-page: 2366
  year: 2011
  ident: 2023103104581345600_bib76
  article-title: Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1111732
– volume: 10
  start-page: 731
  year: 2010
  ident: 2023103104581345600_bib120
  article-title: Association between smoking and chronic kidney disease: a case control study
  publication-title: BMC Public Health
  doi: 10.1186/1471-2458-10-731
– volume: 13
  start-page: 1605
  year: 2018
  ident: 2023103104581345600_bib142
  article-title: Nephrotoxicity and Chinese herbal medicine
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.11571017
– volume: 15
  start-page: e0238111
  year: 2020
  ident: 2023103104581345600_bib121
  article-title: Association of smoking with incident CKD risk in the general population: a community-based cohort study
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0238111
– volume: 63
  start-page: 396
  year: 2014
  ident: 2023103104581345600_bib125
  article-title: Resolving the enigma of the Mesoamerican nephropathy: a research workshop summary
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2013.08.014
– volume: 4
  start-page: 829
  year: 2016
  ident: 2023103104581345600_bib56
  article-title: Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
  publication-title: Lancet Diabetes Endocrinol
  doi: 10.1016/S2213-8587(16)30156-5
– volume: 21
  start-page: 493
  year: 2009
  ident: 2023103104581345600_bib133
  article-title: Human innate immunity against African trypanosomes
  publication-title: Curr Opin Immunol
  doi: 10.1016/j.coi.2009.05.024
– volume: 11
  start-page: 340
  year: 2017
  ident: 2023103104581345600_bib107
  article-title: Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment
  publication-title: Front Med
  doi: 10.1007/s11684-017-0570-3
– volume: 97
  start-page: 2732
  year: 2012
  ident: 2023103104581345600_bib90
  article-title: Preservation of renal function by thyroid hormone replacement therapy in chronic kidney disease patients with subclinical hypothyroidism
  publication-title: J Clin Endocrinol Metabol
  doi: 10.1210/jc.2012-1663
– volume: 11
  start-page: 319
  year: 2000
  ident: 2023103104581345600_bib95
  article-title: Effect of gender on the progression of nondiabetic renal disease: a meta-analysis
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.V112319
– volume: 380
  start-page: 2295
  year: 2019
  ident: 2023103104581345600_bib85
  article-title: Canagliflozin and renal outcomes in type 2 diabetes and nephropathy
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1811744
– volume: 11
  start-page: 569551
  year: 2020
  ident: 2023103104581345600_bib143
  article-title: Nephrotoxicity of herbal medicine and its prevention
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2020.569551
– volume: 128
  start-page: 229
  year: 2015
  ident: 2023103104581345600_bib113
  article-title: The Mediterranean diet, its components, and cardiovascular disease
  publication-title: Am J Med
  doi: 10.1016/j.amjmed.2014.10.014
– volume: 383
  start-page: 1436
  year: 2020
  ident: 2023103104581345600_bib86
  article-title: Dapagliflozin in patients with chronic kidney disease
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2024816
– volume: 387
  start-page: 957
  year: 2016
  ident: 2023103104581345600_bib23
  article-title: Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
  publication-title: Lancet North Am Ed
  doi: 10.1016/S0140-6736(15)01225-8
– volume: 101
  start-page: 1013
  year: 2007
  ident: 2023103104581345600_bib126
  article-title: Chronic renal failure in North Central Province of Sri Lanka: an environmentally induced disease
  publication-title: Trans R Soc Trop Med Hyg
  doi: 10.1016/j.trstmh.2007.05.006
– volume: 369
  start-page: m824
  year: 2020
  ident: 2023103104581345600_bib29
  article-title: Estimated population wide benefits and risks in China of lowering sodium through potassium enriched salt substitution: modelling study
  publication-title: BMJ
  doi: 10.1136/bmj.m824
– volume: 12
  start-page: 1931
  year: 2020
  ident: 2023103104581345600_bib109
  article-title: Plant-dominant low-protein diet for conservative management of chronic kidney disease
  publication-title: Nutrients
  doi: 10.3390/nu12071931
– volume: 391
  start-page: 2346
  year: 2018
  ident: 2023103104581345600_bib30
  article-title: Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
  publication-title: Lancet North Am Ed
  doi: 10.1016/S0140-6736(18)30951-6
– volume: 139
  start-page: 2089
  year: 2019
  ident: 2023103104581345600_bib41
  article-title: 24-Hour blood pressure-lowering effect of an SGLT-2 inhibitor in patients with diabetes and uncontrolled nocturnal hypertension: results from the randomized, placebo-controlled SACRA study
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.118.037076
– volume: 371
  start-page: 993
  year: 2014
  ident: 2023103104581345600_bib67
  article-title: Angiotensin-neprilysin inhibition versus enalapril in heart failure
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1409077
– volume: 2
  start-page: 476
  year: 2020
  ident: 2023103104581345600_bib112
  article-title: Impact of dietary potassium restrictions in CKD on clinical outcomes: benefits of a plant-based diet
  publication-title: Kidney Med
  doi: 10.1016/j.xkme.2020.04.007
– volume: 47
  start-page: 645
  year: 2020
  ident: 2023103104581345600_bib74
  article-title: Diabetic kidney disease
  publication-title: Primary Care: Clinics in Office Practice
  doi: 10.1016/j.pop.2020.08.004
– volume: 39
  start-page: 744
  year: 2016
  ident: 2023103104581345600_bib124
  article-title: Effects of smoking and its cessation on creatinine- and cystatin C-based estimated glomerular filtration rates and albuminuria in male patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry
  publication-title: Hypertens Res
  doi: 10.1038/hr.2016.51
– volume: 380
  start-page: 1880
  year: 2019
  ident: 2023103104581345600_bib83
  article-title: Dapagliflozin and cardiovascular outcomes in type 2 diabetes. Reply
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1812389
– volume: 3
  start-page: 50
  year: 2014
  ident: 2023103104581345600_bib103
  article-title: Obesity in kidney disease: a heavyweight opponent
  publication-title: World J Nephrol
  doi: 10.5527/wjn.v3.i3.50
– volume: 13
  start-page: 422
  year: 2007
  ident: 2023103104581345600_bib61
  article-title: High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database
  publication-title: J Card Fail
  doi: 10.1016/j.cardfail.2007.03.011
– volume: 37
  start-page: 3164
  year: 2014
  ident: 2023103104581345600_bib119
  article-title: Smoking and long-term risk of type 2 diabetes: the EPIC-InterAct study in European populations
  publication-title: Diabetes Care
  doi: 10.2337/dc14-1020
– volume: 68
  start-page: 344
  year: 2016
  ident: 2023103104581345600_bib127
  article-title: Uddanam nephropathy/regional nephropathy in India: preliminary findings and a plea for further research
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2016.04.012
– volume: 358
  start-page: 2545
  year: 2008
  ident: 2023103104581345600_bib10
  article-title: Effects of intensive glucose lowering in type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0802743
– volume: 14
  start-page: 1657
  year: 2021
  ident: 2023103104581345600_bib71
  article-title: Chronic kidney disease progression among patients with type 2 diabetes identified in US administrative claims: a population cohort study
  publication-title: Clin Kidney J
  doi: 10.1093/ckj/sfaa200
– volume: 87
  start-page: 332
  year: 2015
  ident: 2023103104581345600_bib137
  article-title: Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1
  publication-title: Kidney Int
  doi: 10.1038/ki.2014.270
– volume: 84
  start-page: 1207
  year: 2013
  ident: 2023103104581345600_bib138
  article-title: JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy
  publication-title: Kidney Int
  doi: 10.1038/ki.2013.173
– volume: 32
  start-page: 239
  year: 2021
  ident: 2023103104581345600_bib114
  article-title: Modifiable lifestyle factors for primary prevention of CKD: a systematic review and meta-analysis
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2020030384
– volume: 385
  start-page: 2507
  year: 2021
  ident: 2023103104581345600_bib39
  article-title: Chlorthalidone for hypertension in advanced chronic kidney disease
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2110730
– volume: 33
  start-page: 1192
  year: 2010
  ident: 2023103104581345600_bib12
  article-title: Usefulness of assessing masked and white-coat hypertension by ambulatory blood pressure monitoring for determining prevalent risk of chronic kidney disease: the Ohasama study
  publication-title: Hypertens Res
  doi: 10.1038/hr.2010.139
– volume: 142
  start-page: 746
  year: 2015
  ident: 2023103104581345600_bib128
  article-title: Heat stress, dehydration, and kidney function in sugarcane cutters in El Salvador—a cross-shift study of workers at risk of Mesoamerican nephropathy
  publication-title: Environ Res
  doi: 10.1016/j.envres.2015.07.007
– volume: 352
  start-page: 225
  year: 2005
  ident: 2023103104581345600_bib70
  article-title: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa043399
– volume: 41
  start-page: 135
  year: 2016
  ident: 2023103104581345600_bib129
  article-title: Mesoamerican nephropathy or global warming nephropathy?
  publication-title: Blood Purif
  doi: 10.1159/000441265
– volume: 28
  start-page: iv82
  year: 2013
  ident: 2023103104581345600_bib105
  article-title: Effects of weight loss on renal function in obese CKD patients: a systematic review
  publication-title: Nephrol Dialysis Transpl
  doi: 10.1093/ndt/gft302
– volume: 6
  start-page: 605
  year: 2018
  ident: 2023103104581345600_bib80
  article-title: Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
  publication-title: Lancet Diabetes Endocrinol
  doi: 10.1016/S2213-8587(18)30104-9
– year: 2021
  ident: 2023103104581345600_bib8
  article-title: 2021 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States
– volume: 43
  start-page: 99
  year: 2017
  ident: 2023103104581345600_bib42
  article-title: Effects of reducing blood pressure on renal outcomes in patients with type 2 diabetes: focus on SGLT2 inhibitors and EMPA-REG OUTCOME
  publication-title: Diabetes Metab
  doi: 10.1016/j.diabet.2016.12.010
– volume: 35
  start-page: 455
  year: 2014
  ident: 2023103104581345600_bib60
  article-title: Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/eht386
– volume: 376
  start-page: 875
  year: 2010
  ident: 2023103104581345600_bib66
  article-title: Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
  publication-title: Lancet North Am Ed
  doi: 10.1016/S0140-6736(10)61198-1
– volume: 31
  start-page: 2233
  year: 2015
  ident: 2023103104581345600_bib94
  article-title: Can levothyroxine treatment reduce urinary albumin excretion rate in patients with early type 2 diabetic nephropathy and subclinical hypothyroidism? A randomized double-blind and placebo-controlled study
  publication-title: Curr Med Res Opin
  doi: 10.1185/03007995.2015.1094044
– year: 2010
  ident: 2023103104581345600_bib116
  article-title: How Tobacco Smoke Causes Disease: the Biology and Behavioral Basis for Smoking-Attributable Disease: a Report of the Surgeon General
– volume: 345
  start-page: 861
  year: 2001
  ident: 2023103104581345600_bib79
  article-title: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa011161
– volume: 78
  start-page: 142
  year: 2021
  ident: 2023103104581345600_bib37
  article-title: Finerenone reduces new-onset atrial fibrillation in patients with chronic kidney disease and type 2 diabetes
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2021.04.079
– volume: 16
  start-page: 251
  year: 2020
  ident: 2023103104581345600_bib3
  article-title: The impact of chronic kidney disease on global health
  publication-title: Nat Rev Nephrol
  doi: 10.1038/s41581-020-0268-7
– volume: 177
  start-page: 1498
  year: 2017
  ident: 2023103104581345600_bib24
  article-title: Association between more intensive vs less intensive blood pressure lowering and risk of mortality in chronic kidney disease stages 3 to 5: a systematic review and meta-analysis
  publication-title: JAMA Intern. Med
  doi: 10.1001/jamainternmed.2017.4377
– volume: 27
  start-page: 1202
  year: 2016
  ident: 2023103104581345600_bib25
  article-title: Urinary sodium and potassium excretion and CKD progression
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2015010022
– volume: 75
  start-page: 1178
  year: 2020
  ident: 2023103104581345600_bib62
  article-title: Diuretic therapy for patients with heart failure: JACC state-of-the-art review
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2019.12.059
– volume: 385
  start-page: 2252
  year: 2021
  ident: 2023103104581345600_bib38
  article-title: Cardiovascular events with finerenone in kidney disease and type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2110956
– volume: 34
  start-page: 509
  year: 2014
  ident: 2023103104581345600_bib118
  article-title: Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.113.300156
– volume: 30
  start-page: 282
  year: 2015
  ident: 2023103104581345600_bib89
  article-title: The relationship between thyroid function and estimated glomerular filtration rate in patients with chronic kidney disease
  publication-title: Nephrol Dialysis Transpl
  doi: 10.1093/ndt/gfu303
– volume: 75
  start-page: 894
  year: 2020
  ident: 2023103104581345600_bib40
  article-title: Antihypertensive and renal mechanisms of SGLT2 (Sodium-Glucose Linked Transporter 2) inhibitors
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.119.11684
– volume: 363
  start-page: 2385
  year: 2010
  ident: 2023103104581345600_bib69
  article-title: Cardiac-resynchronization therapy for mild-to-moderate heart failure
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1009540
– volume: 362
  start-page: 1575
  year: 2010
  ident: 2023103104581345600_bib21
  article-title: Effects of intensive blood-pressure control in type 2 diabetes mellitus
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1001286
– volume: 16
  start-page: 223
  year: 2020
  ident: 2023103104581345600_bib6
  article-title: The global epidemiology of hypertension
  publication-title: Nat Rev Nephrol
  doi: 10.1038/s41581-019-0244-2
– volume: 26
  start-page: 1258
  year: 2003
  ident: 2023103104581345600_bib73
  article-title: Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes
  publication-title: Diabetes Care
  doi: 10.2337/diacare.26.4.1258
– volume: 8
  start-page: 593
  year: 2013
  ident: 2023103104581345600_bib93
  article-title: Hypothyroidism and mortality among dialysis patients
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.06920712
– volume: 394
  start-page: 131
  year: 2019
  ident: 2023103104581345600_bib81
  article-title: Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
  publication-title: Lancet North Am Ed
  doi: 10.1016/S0140-6736(19)31150-X
– volume: 82
  start-page: 561
  year: 2007
  ident: 2023103104581345600_bib141
  article-title: Use of herbs among adults based on evidence-based indications: findings from the National Health Interview Survey
  publication-title: Mayo Clin Proc
  doi: 10.4065/82.5.561
– volume: 316
  start-page: 1997
  year: 2016
  ident: 2023103104581345600_bib53
  article-title: Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force Recommendation Statement
  publication-title: JAMA
  doi: 10.1001/jama.2016.15450
– volume: 20
  start-page: 33
  year: 2009
  ident: 2023103104581345600_bib131
  article-title: Hereditary kidney disorders
  publication-title: EJIFCC
– volume: 373
  start-page: 2103
  year: 2015
  ident: 2023103104581345600_bib11
  article-title: A randomized trial of intensive versus standard blood-pressure control
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1511939
– volume: 99
  start-page: S1
  year: 2021
  ident: 2023103104581345600_bib17
  article-title: KDIGO 2021 Clinical Practice Guideline for the management of blood pressure in chronic kidney disease
  publication-title: Kidney Int
  doi: 10.1016/j.kint.2020.11.003
– volume: 14
  start-page: 1788
  year: 2019
  ident: 2023103104581345600_bib5
  article-title: Advancing American kidney health: an introduction
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.11840919
– volume: 22
  start-page: 1619
  year: 2007
  ident: 2023103104581345600_bib104
  article-title: Impact of weight change on albuminuria in the general population
  publication-title: Nephrol Dialysis Transpl
  doi: 10.1093/ndt/gfm091
– volume: 46
  start-page: 871
  year: 2005
  ident: 2023103104581345600_bib100
  article-title: Association between body mass index and CKD in apparently healthy men
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2005.08.015
– volume: 24
  start-page: 722
  year: 2013
  ident: 2023103104581345600_bib139
  article-title: Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2012121180
– volume: 385
  start-page: 1067
  year: 2021
  ident: 2023103104581345600_bib28
  article-title: Effect of salt substitution on cardiovascular events and death
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2105675
– volume: 377
  start-page: 2195
  year: 2017
  ident: 2023103104581345600_bib82
  article-title: Liraglutide and renal outcomes in type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1616011
– volume: 68
  start-page: 501
  year: 2016
  ident: 2023103104581345600_bib13
  article-title: Masked hypertension and cardiovascular disease events in a prospective cohort of Blacks: the Jackson Heart Study
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.116.07553
– volume: 13
  start-page: 261
  year: 2020
  ident: 2023103104581345600_bib130
  article-title: Mesoamerican nephropathy (MeN): what we know so far
  publication-title: Int J Nephrol Renovasc Dis
  doi: 10.2147/IJNRD.S270709
– volume: 341
  start-page: 709
  year: 1999
  ident: 2023103104581345600_bib65
  article-title: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199909023411001
– volume: 121
  start-page: 3367
  year: 2011
  ident: 2023103104581345600_bib134
  article-title: Genetics of kidney failure and the evolving story of APOL1
  publication-title: J Clin Invest
  doi: 10.1172/JCI46263
– volume: 354
  start-page: 131
  year: 2006
  ident: 2023103104581345600_bib33
  article-title: Efficacy and safety of benazepril for advanced chronic renal insufficiency
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa053107
– volume: 358
  start-page: 2560
  year: 2008
  ident: 2023103104581345600_bib75
  article-title: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0802987
– volume-title: Endotext
  year: 2000
  ident: 2023103104581345600_bib52
  article-title: Dyslipidemia in chronic kidney disease
– volume: 23
  start-page: 654
  year: 2013
  ident: 2023103104581345600_bib91
  article-title: Thyroid hormone replacement therapy attenuates the decline of renal function in chronic kidney disease patients with subclinical hypothyroidism
  publication-title: Thyroid
  doi: 10.1089/thy.2012.0475
– volume: 62
  start-page: 1743
  year: 2002
  ident: 2023103104581345600_bib49
  article-title: Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.2002.00626.x
– volume: 2011
  start-page: 1
  year: 2011
  ident: 2023103104581345600_bib99
  article-title: Testosterone increases: sodium reabsorption, blood pressure, and renal pathology in female spontaneously hypertensive rats on a high sodium diet
  publication-title: Adv Pharmacol Sci
– volume: 383
  start-page: 1413
  year: 2020
  ident: 2023103104581345600_bib68
  article-title: Cardiovascular and renal outcomes with empagliflozin in heart failure
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2022190
– volume: 157
  start-page: 107843
  year: 2019
  ident: 2023103104581345600_bib72
  article-title: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2019.107843
– volume: 360
  start-page: 129
  year: 2009
  ident: 2023103104581345600_bib77
  article-title: Glucose control and vascular complications in veterans with type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0808431
– volume: 377
  start-page: 2097
  year: 2017
  ident: 2023103104581345600_bib84
  article-title: Canagliflozin and cardiovascular and renal events in type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1611925
– volume: 7
  start-page: 71
  year: 2017
  ident: 2023103104581345600_bib144
  article-title: Reducing major risk factors for chronic kidney disease
  publication-title: Kidney Int Suppl
  doi: 10.1016/j.kisu.2017.07.003
– volume: 64
  start-page: 744
  year: 2014
  ident: 2023103104581345600_bib16
  article-title: Assessment of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2014.06.014
– volume: 360
  start-page: 7
  year: 2002
  ident: 2023103104581345600_bib55
  article-title: Heart Protection Study Collaborative G. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial
  publication-title: Lancet North Am Ed
– volume: 14
  start-page: 1441
  year: 2019
  ident: 2023103104581345600_bib108
  article-title: Healthy dietary patterns and incidence of CKD: a meta-analysis of cohort studies
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.00530119
– start-page: CD007784
  year: 2014
  ident: 2023103104581345600_bib58
  article-title: HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
  publication-title: Cochrane Database Syst Rev
– volume: 327
  start-page: 669
  year: 1992
  ident: 2023103104581345600_bib64
  article-title: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199209033271001
– volume: 123
  start-page: 754
  year: 1995
  ident: 2023103104581345600_bib18
  article-title: Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-123-10-199511150-00003
– volume: 21
  start-page: 252
  year: 2020
  ident: 2023103104581345600_bib47
  article-title: The association between dyslipidemia and the incidence of chronic kidney disease in the general Zhejiang population: a retrospective study
  publication-title: BMC Nephrology
  doi: 10.1186/s12882-020-01907-5
– ident: 2023103104581345600_bib140
  article-title: Phase 2/3 adaptive study of VX-147 in adults with APOL1- mediated proteinuric kidney disease
– volume: 32
  start-page: 424
  year: 2021
  ident: 2023103104581345600_bib34
  article-title: Stopping renin-angiotensin system inhibitors in patients with advanced CKD and risk of adverse outcomes: a nationwide study
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2020050682
– volume: 46
  start-page: 587
  year: 2005
  ident: 2023103104581345600_bib101
  article-title: Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2005.06.007
– volume: 23
  start-page: 92
  year: 2021
  ident: 2023103104581345600_bib122
  article-title: Smoking, smoking cessation, and progression of chronic kidney disease: results from KNOW-CKD Study
  publication-title: Nicotin Tob Res
  doi: 10.1093/ntr/ntaa071
– volume: 365
  start-page: 939
  year: 2005
  ident: 2023103104581345600_bib20
  article-title: Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial
  publication-title: Lancet North Am Ed
  doi: 10.1016/S0140-6736(05)71082-5
SSID ssj0000851045
Score 2.3993566
SecondaryResourceType review_article
Snippet Chronic kidney disease (CKD) and its downstream complications (i.e. cardiovascular) are a major source of morbidity worldwide. Additionally, deaths due to CKD...
ABSTRACT Chronic kidney disease (CKD) and its downstream complications (i.e. cardiovascular) are a major source of morbidity worldwide. Additionally, deaths...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
oup
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1737
SubjectTerms Blood pressure
Cardiology
Chronic illnesses
Chronic kidney failure
CKJ Review
Clinical trials
Dapagliflozin
Denervation
Development and progression
Diabetes
Drug therapy
Health aspects
Hydrochlorothiazide
Hyperkalemia
Hypertension
Hypothyroidism
Ivabradine
Kidney diseases
Lifestyles
Mortality
Prevention
Public health
Risk factors
Testosterone
Thyroid hormones
Type 2 diabetes
Weight control
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Na9wwEB3a9FIopU364XbTqBAIFMR6ZVuyTiGEhlBITg3sTciSTLcp3iS7OfTfd8bSeuNQcpYsCY80ejOaeQNwqL1rvGg0177yvKxsyXXQijczVzVKhZnrXQMXl_L8qvwxr-bJ4bZKYZUbndgrar905COf4j2HxohSRXV8c8upahS9rqYSGs_hBVGXUUiXmqvBx0JwIu_rFBM9La_xtk8pemjHT9317-mqtX6WCsJsLqWkmkf5bg9g5-PoyQfX0dkbeJ1wJDuJgn8Lz0K3C6-iE47F3KI98NvgFrZsGY7jF9H3xyiknKViOwyBK0MgyPw2gojZzrM-eCsSd9D3LhLpsuuF78Jflt523sHV2fefp-c8lVXgrlLlmqMNo4NsBSILNB5da0shghK-rFvEMkXQVnsrtJfCEaIKjVaO8nNz3Urb-Lp4DzvdsgsfgVkpc-8QEslQlHUQeiZkaxulnW8FQosMvm3-q3GJc5xKX_wx8e27MCgEk4SQweHQ-SZSbfy_2xEJyNABxLGcTXkEuCKisjInClUOqvFKZjAZ9cSD40bNByjip6eabMRv0tFeme1GzODr0ExjU7haF5b3KyPqusI5ZC4y-BB3yzBPoTRCyBynr0f7aOhAhN_jlm7xqyf-JvOdGNg-Pb2uz_AShVvEjMkJ7Kzv7sM-Qqd186U_H_8AKu0Zyg
  priority: 102
  providerName: ProQuest
Title Management of traditional risk factors for the development and progression of chronic kidney disease
URI https://www.ncbi.nlm.nih.gov/pubmed/37915906
https://www.proquest.com/docview/3171847735
https://www.proquest.com/docview/2885538602
https://pubmed.ncbi.nlm.nih.gov/PMC10616454
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dSxwxEB_8ePFFWrR22-uZglAobL3L7iabh1JsUUTQluLBvYVsksVT2aveCfrfd2aTO12R0pd9ydcymSS_SWZ-A7CnnK0cr1SqXOHSvDB5qrySaTW0RSWlH9r2auD0TByP8pNxMV6BRTLOKMDZi6Yd5ZMa3V5_ub95-IYL_mskQ9q3V5f7s9q4IcVxreORJGmFnkacfxmcsdDsIHdG4qlNSzz2Y6zes_ad0ynu0Z3Atyf487kb5ZNz6egVbEZAyQ6CBryGFd9sgXv0amHTmmE7NwmXfox8yVnMssMQsTJEgMw9ug4x0zjWem0Fxg5qbwODLruauMY_sPiosw2jo8PzH8dpzKeQ2kLm8xSNF-VFzRFSoNVoa5Nz7iV3eVkjiMm8MsoZrpzglqCUr5S0FJg7ULUwlSuzN7DWTBv_FpgRYuAsYiHhs7z0XA25qE0llXU1R0yRwOeFHLWNZOOU8-Jah0fvTKPQdRR6AnvLyn8Cx8bL1T7RhGjSBezLmhhAgH9EHFb6QOJeg_t3IRLodWriirGd4l2c0n8P1VtMt16opEakheawlFmRwMdlMfVNfmqNn97NNC_LAscQA57ATtCO5TiZVIgdBzh82dGbZQVi-u6WNJOLlvGb7HaiXnv33yJ4Dxs4z1mImuzB2vz2zn9A-DSv-rAqx7IP698Pz3797reXEP12ueD3_Of4L0ZmIHo
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3daxQxEB_q9UGhiN-unjZCRRCW28vuJpsHkaotV9seIi30LWaTLF4re9W7Iv2n_BudbLJ7XZG-9TnZSdiZZH4zmQ-ALWF0aWgpYmFyE2e5ymJhBY_Lsc5Lzu1YN66BwymbHGefT_KTNfjT5sK4sMr2TmwuajPXzkc-Qj2Hxgjnaf7-_Gfsuka519W2hYYXi317-RtNtsW7vU_I39eU7u4cfZzEoatArHOeLWOE8MKyCo1-tG2orlRGqeXUZEWFqjy1QgmjqDCMagcobCm4dumpiaiYKk2RIt1bsJ6laMoMYP3DzvTL186r4wBM0nRGdgVx4wLxRUgKTEQ60meno0WlzDi0oGnVYFAGvQy7K0D333jNKwpw9x7cDciVbHtRuw9rtn4AG97tR3w200Mwq3AaMq8I0jEz720kLoidhPY-BKEyQehJzCpmiajakCZczJcKcd9rX7qXnM1MbS9JeE16BMc38ssfw6Ce1_YpEMVYYjSCMGbTrLBUjCmrVMmFNhVFMBPB2_a_Sh2qnLtmGz-kf21PJTJBBiZEsNVNPvfFPf4_7Y1jkHRHHmlpFTIXcEeueJbc5njJoeLIWQTD3kw8qro3vIksvn6pYct-GS6ThVyJfgSvumFH2wXI1XZ-sZC0KHJcgyU0gideWrp1Ui4QtCa4fNGTo26CKzHeH6ln35tS485h4Gq-Pbt-X5twe3J0eCAP9qb7z-EOMjr1-ZpDGCx_XdgXCNyW5ctwWgh8u-kD-heXqFbH
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Management+of+traditional+risk+factors+for+the+development+and+progression+of+chronic+kidney+disease&rft.jtitle=Clinical+kidney+journal&rft.au=Lo%2C+Robin&rft.au=Narasaki%2C+Yoko&rft.au=Lei%2C+Sean&rft.au=Rhee%2C+Connie+M&rft.date=2023-11-01&rft.pub=Oxford+University+Press&rft.issn=2048-8505&rft.volume=16&rft.issue=11&rft.spage=1737&rft_id=info:doi/10.1093%2Fckj%2Fsfad101&rft.externalDocID=A779353856
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2048-8505&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2048-8505&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2048-8505&client=summon